Inside medical cannabis concentrates: hash and rosin reach the international shelf
In May 2026 the United Kingdom listed its first medical hash — Canadian-sourced static hash, crumble and ice-water hash — the clearest sign yet that concentrates are crossing from adult-use shelves into international medical markets. On our tracker that shelf is still gated by GMP-compliant supply, and price follows process, not potency: rosin holds a […]
Germany Imports 201 Tonnes of Medical Cannabis in 2025 and Crosses €1 Billion in Sales
Germany’s pharmacy sell-out market surpassed €1 billion for the first time in 2025, with imports reaching a record 201.1 tonnes (+176% YoY) — making it the largest regulated medical cannabis market globally. This data brief examines the supply chain diversification that accompanied that growth, the regulatory and pricing pressures now reshaping the operator landscape, the […]
Hemp Under Siege, Telemedicine Squeezed — November 2025 Brief
Hemp and CBD restrictions reshape access and redraw the global cannabis geoeconomy
Legalisation Momentum Meets Regulatory Headwinds — October 2025 Brief
Access the database with +5,000 regulation updates, market reports and science papers on the international cannabis market. October 2025 highlighted a decisive shift toward regulatory expansion across the global cannabis landscape. Import quotas rose, hospital and pharmacy access widened, and several countries advanced long-awaited legal frameworks — signalling renewed political momentum. Yet these openings coexist with […]
Regulatory scrutiny fuels market instability — September 2025 Brief
September 2025 underscored the tension between rising demand and tightening compliance across global cannabis supply chains. Imports, prescriptions, and economic contributions continue to climb, yet regulatory reviews multiply — with stricter prescribing rules and compliance crackdowns reshaping access. Some countries move boldly toward reform, while others drift in regulatory grey zones — marking a sector entering […]
Global Market Grows Under Tightening Rules – August 2025 Brief
Diverging access and mounting constraints define the next phase of global cannabis amid fragile supply chains.
The Transatlantic Cannabis Triangle: Canada, Portugal & Germany Under Pressure
Germany has rapidly become the world’s leading medical cannabis market since legalisation in April 2024. Imports more than doubled from 32.5 tonnes in 2023 to 71.6 tonnes in 2024. The second quarter of 2025 alone saw imports of 43 tonnes, with over 132 tonnes imported in the last 4 quarters. Current projections suggest Germany could […]
Momentum Builds Unevenly in Global Cannabis Reform — July 2025 Brief
This month’s brief captures a pivotal moment in the global cannabis sector, as reform momentum continues but faces intensifying regulatory headwinds. Governments are tightening oversight on prescribing and distribution — with telemedicine under the spotlight in Germany and Australia — as markets adapt to shifting access models and research adds fresh weight to the public […]
From Bans to Breakthroughs: Markets Evolve Amid Legal and Market Shifts — June 2025 Brief
Hi , welcome to the Cannamonitor brief. This month, we track the global cannabis sector’s steady evolution, with regulators tightening control, businesses innovating amid rising demand, and new research underscoring cannabis’ potential role in public health. We highlight Germany’s regulatory clampdown on telemedicine and record medical imports, Poland’s rebound through hybrid clinics, and Australia’s prescription […]
Germany’s Medical Cannabis Market Boom Continues in 2025 Despite Policy Shifts
Germany has rapidly become Europe’s most significant medical cannabis market, and one of the most influential worldwide. In 2024, medical cannabis imports reached an unprecedented 71.6 tonnes, more than doubling the previous year’s figure of 32.5 tonnes. This marked acceleration—driven by regulatory liberalisation, rapid growth in patient demand, and an expanding supply chain—has positioned Germany […]